Public attitude toward COVID-19 medicines in Russia 2020

Published by Statista Research Department, Mar 4, 2021
More than one half of Russians stated that they would not purchase COVID-19 medicines if they were costly, according to a survey conducted in the fourth quarter of 2020. Furthermore, approximately 45 percent held the view that such products should be available to purchase only with a prescription.

Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement

CharacteristicShare of respondents
Would not purchase a COVID-19 medicine if its price was high 53%
COVID-19 medicines should be sold strictly by prescription 45.1%
Immune system boosting medicines are the best COVID-19 prevention method 33.2%
Showing entries 1 to 3 (3 entries in total)
Created with Highcharts 7.2.2Share of respondents53%53%45.1%45.1%33.2%33.2%Would not purchase a COVID-19 medicine if its price was highCOVID-19 medicines should be sold strictly by prescriptionImmune system boosting medicines are the best COVID-19 preventionmethod
0%5%10%15%20%25%30%35%40%45%50%55%60%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2021

Region

Russia

Survey time period

Q4 2020

Number of respondents

4,874 respondents

Special properties

in cities with 100k+ population

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on " Coronavirus (COVID-19) in Russia "

Other statistics that may interest you Coronavirus (COVID-19) in Russia

Overview

8

Prevention & diagnostics

6

Medicines and health products

6

Economic impact

4

Impact on selected industries

7

Public opinion

4

Further related statistics

9

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Medication and medical treatments in JapanHealth and functional foods market in JapanState of health in JapanWellness in JapanCancer in Japan
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.